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Director of Thesis:

Preimplantation mouse embryos (PIEs) were
investigated in vitro to determine the influence of
17-~-estradiol and tamoxifen on protein profiles.
Stage-specific mouse embryos (2-cell, 4-cell, and 8-cell)
were cultured for 8 hours in Whitten's Modified Medium
supplemented with 17-~-estradiol and/or tamoxifen.

Upon

completion of the culturing process, PIEs were analyzed
for embryogenetic progression.

Following viability

studies, PIEs were exposed to electrophoresis in two
dimensions to obtain protein profiles for observational
comparative analysis.

Resultant data show that

enhancement of protein synthesis will not result from
exogenous supplements of 17-~-Estradiol in 2-cell, 4-cell
and 8-cell PIEs.

Viability and electrophoretic studies

demonstrate that 4-cell and 8-cell PIEs are estrogen
dependent and that endogenous estrogen production occurs
in 4-cell and 8-cell PIEs.

Tamoxifen is shown to be an

effective antiestrogenic agent.
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Evidence obtained

support the concept of embryonic genome initation at the
late.2-cell PIE stage.
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CHAPTER I

INTRODUCTION

An understanding of the. concepts related to early
mammalian embryology has been the focus of study for
developmental biologists for more than a century.

Within

the last forty years, research efforts detailing the
mechanisti9 theories of mammalian development have
resulted in the evolution of modern technologies.used by
today's investigators (Johnson, 1977).

Acceptance of

molecular approaches to scientific inquiry has recently
generated significant knowledge concerning embryological
events following fertilization.

Laboratory studies,

using the rodent model (mostly mice), have yielded data
important to the understanding of the timing of
developmental events, the potency of the preimplantation
embryo, and the fates of cells during early
embryogenesis.
Advances in experimental molecular research were
delayed until the late 1950's as a result of insufficient
biotechnical capabilities (Slack, 1983).

Mammalian

studies were particularly suppressed, because direct
observations of preimplantation embryos were not possible
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in viviparous mammals.

The study of developmental events

for mammals required the isolation of preimplantation
embryos, and the establishment of tissue culture
techniques essential to the survival of the developing
embryo.
were:

Tissue culture problems that had to be resolved
(1)

the maximization of embryo yield and

developmental uniformity through in vitro culturing
(Gates, 1971);

(2)

the development of manipulation

techniques for handling living embryos (Bedford, 1971);
and

(3)

the development of microanalytical techniques

applicable to the relatively small volume of experimental
materials (Johnson, 1977).
Efforts to maximize embryo yield and developmental
uniformity have been numerous.

Initial problems

associated with embryo yield were centered on superovulation, particularly in the mouse model (Edwards and
Gates, 1959;

Gates, 1971).

Chang (1959) and Whittingham

(1968) successfully identified those conditions essential
to the in vitro culturing of unfertilized ova.

The

results of these studies allowed for the successful
maintenance of viable ova, and the subsequent in vitro
fertilization.

Culturing procedures for mouse

preimplantation embryos were developed by Brinster
(1968), and Biggers, et al. (1971).

3

·Maintenance of preimplantation embryos, through the
culturing process, required the development of specific
manipulation skills to ensure embryo survival.

Apparatus

essential for the transfer of embryos from recovery
through the early cleavage stages, while in the culture
medium, included a variety of micromanipulating tools
(Tarkowski, 1961;

Mintz, 1962).

The development of a

new generation of laboratory equipment, such as micropipetors and microscopes, have enhanced the manipulation
of viable embryos.
Advances in microanalytical techniques in cellular
and molecular biology, such as electrophoresis, have made
possible the evaluation of small volumes of experimental
materials.

Application of microanalytical techniques,

with sufficient sensitivity for the detection of specific
proteins and RNA synthesis, has provided researchers the
ability to determine the macromolecular composition of
embryonic tissues (Bolton, et al., 1984;
Bolton, 1985).

Howlett and

The sensitivity of these techniques

allows for the identification of specific ions in
preimplantation embryos (PIEs)

(Kaye, 1986).

Data

obtained through microanalytical investigations provide
deve~opmental biologists a basis for better understanding
the events in early embryonic development based on
dynamic molecular interactions.

4

superovulation

Laboratory research using superovulation techniques
to collect fertilized mouse ova was first reported by
Fowler and Edwards (1957).

In this study, female mice

were given intraperitoneal injections of two gonadotropins, pregnant mares' serum gonadotropin (PMSG)
followed by human chorionic gonadotropin (hCG).
Gonadotropin dosage varied from 2-10 international units,
as reported by different researchers.

Injections of

gonadotropins stimulated mice to superovulate (Edwards
and Gates, 1959),

thereby, producing approximately three

times as many ova as are produced through spontaneous
ovulation (Gates, 1971).

Hormone injections,

administered 44-48 hours apart were shown to regulate the
time of ovulation and allow the collection of PIEs at
specific stages of embryological development (Edwards and
Gates, 1959).

Thus, 2-cell PIEs were collected 45 hours

post-hCG injection (Brinster, 1965a), 4-cell PIEs were
collected 54 hours post-hCG injection (Brinster, 1967),
and a-cell PIEs were collected 64 hours post-hCG
injection (Warner and Tollefson, 1978).
The selection of the mouse strain for superovulation
has been reported as being significant, because
various
,
strains produce different numbers of ova when hormonestimulated (McLaren, 1967).

Gates and Runner (1957)
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reported that outbred mouse strains generated greater
numbers of viable ova through superovulation than did
inbred mouse strains, because outbred strains have a more
vigorous reproductive capacity.

In addition, Gates

(1971) demonstrated that prepuberal female mice (three
weeks of age) produced the highest yield of ova when
hormone-stimulated.

This increase in superovulation

activity resulted from a wave of follicle maturation in
prepuberal mice.
Controlled lighting conditions were shown to be
essential to the collection of PIEs following hormone
stimulation (Whitten and Dagg, 1961).

A photoperiod

utilizing a typical light regime, between 12 and 14 hours
duration, resulted in maximum PIE recovery.

Maintenance

of the mice under a controlled photoperiod was required
to accurately time the occurrence of ovulation (Gates,
1971).

Under natural conditions, the surge of

luteinizing hormone (LH) release correlates with the
daily light/dark photoperiod and, subsequently, the
ovulation of mature Graafian follicles (Schultz, 1986).
Research has shown that the time interval between peak LH
release and ovulation to be approximately 9 hours (Gates,
1969) •
Pregnant mares' serum gonadotropin treated mice
release LH 11-16 hours after the second midpoint

6

(12:00 a.m.) of the dark period (Gates, 1969), about
47 - 52 hours after injection (Figure 1).

PMSG contains

follicle stimulating hormone activity (FSH), which
induces preovulatory maturation of ovarian follicles.
The PMSG injection assured the development of mature
Graafian follicles preceding LH stimulation (Schultz,
1986).

To regulate the time of ovulation,

experimental

animals were injected with hCG at 45 hours post-PMSG
injection (Fowler and Edwards, 1957;

Kendall, 1979).

Human Chorionic Gonadotropin contains ovulatory hormone
LH-like activity, and Edwards and Gates (1959) reported
that o~ulation by exogenous LH induction required a time
lapse of 12 hours.

Whittingham (1967), working with a

random bred strain of Swiss mice, reported that ovulation
occurred 10.5 - 12.5 hours post-hCG injection.
Consequently, hCG injection must be administered 3 hours
prior to endogenous activation (Gates, 1971).

Embryogenesis

Fertilized ova undergo a series of cleavage
divisions, cell division without growth, that transform
the single-celled zygote into a multicellular blastocyst
(Figure 2).

These preimplantation divisions begin

approximately 24 hours after fertilization, with
subsequent divisions occurring about every 12 hours.

At
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5 IU PMSG~
Female Mouse

(12 p.m.)

12 hrs
12 a.m.

(First Midpoint)

24 hrs

12 a.m.

(Second Midpoint)
11-16 hrs later LH

release begins
9

hrs

5 IU h C G ~
Female Mouse

(9a.m.).
to regulate ovulation
time hCG was injected 3
hrs prior to approximate
LH peak

Ovulation

(9 p.m.)

Figure 1. Time intervals and considerations for hormone
induced superovulation.
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Ovulation
and
Fertilization
Meiosis II

1-Cell. stage
(Day 1)

2-Cell Stage
(Day 2)

4-Cell Stage

Oviduct
8-Cell Stage
(Day 3)

8-Cell Stage
(Compaction)

Uterus

Figure 2. Diagrammatic outline of mouse early
embryogene_sis (Schultz, 1986).
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the a-cell stage, approximately 60 hours after
fertilization, the embryo assumes a spherical shape
through morphological reorganization;

through the

process of compaction (Johnson and Maro, 1986).

The

molecular events of compaction are dependent upon sterol
synthesis, glycosylation of membrane proteins, and
organization of a distinct network of microfilaments
(Brachet and Alexandre, 1986).

The process of compaction

continues until the embryo reaches the 32-cell stage,
when the fluid-filled blastocoel first appears (Slack,
1983)'.

During compaction, blastomeres flatten against

each other to maximize intercellular contacts.

Contact

establishes both tight and gap junctional communications,
and results in the disappearance of interblastomere
furrows.

As the compaction process continues, the

cellular components of each blastomere undergo a
rearrangement that transforms the cell pattern from a
non-polarized to a radially polarized pattern (Schultz,
1986).

The tight junctions formed during compaction fix

the positions of the blastomeres preventing blastomere
movement.

Polarization of the blastomeres establishes an

inside-outside orientation, which is maintained as
cleavage continues.

The overall process of compaction is

ca 2+ dependent (Slack, 1983.; Yamamura and Spindle, 1988).
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Following compaction, continued cleavage activity
transforms the embryo into a blastocyst as it enters the
uterine cavity.

The blastocyst is composed of two

distinct committed tissues, an outer band of
trophectodermal cells surrounding a small group of inner
cell mass cells that are positioned at one end of the
blastocoel.

Tarkowski and Wroblewska (1967) demonstrated

that different environmental conditions, to which
blastomeres were exposed, played a decisive role in the
differentiation of the trophectoderm and the inner cell
mass.

This hypothesis, known as the inside-outside or

epigenetic hypothesis, suggests that blastomeres remain
totipotent through the random polarization process of the
morula (Pedersen, 1986).

studies using the inner and

outer positioned blastomeres of 16- and 32-cell embryos
have supported this cell potency concept (Spindle, 1978;
Rossant and Vijh, 1980;

Ziomek, et al., 1982).

Preimplantation Culturing

The initial problem, to be resolved for the study of
mammalian embryonic development, was the advancement of
suitable in vitro culturing techniques (Biggers, et al.,
1971).

The principle mammal used in research involving

culturing techniques has been various strains of
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laboratory mice (Brinster, 1969a and b;
1971;

Whitten, 1971;

Whittingham,

Biggers, et al., 1971).

The initial report of in vitro observations of mouse
embryos was made by Hammond (1949).

In his report,

Hammond stated that successful culturing of mouse embryos
depended on the age of the embryo being cultured;
attempts to culture 2-cell embryos were not successful,
but 8-cell embryos were cultured to the blastocyst stage.
The culture medium developed by Hammond was physiological
saline, supplemented with hen egg whites and yolk.
Whitten (1956a) modified the culture medium
developed by Hammond by substituting Krebs-Ringer
bicarbonate solution, as the physiological saline, in an
attempt to control the pH of the medium (Table 1).

Other

additions to the culture medium were glucose, penicillin,
and streptomycin.

Initially, Whitten maintained the use

of egg whites in his medium, but discontinued the use of
egg yolk.

Through experimentation, Whitten determined

that crystalline bovine serum albumin was a beneficial
substitution for the egg whites.

Further, Whitten gassed

the medium with 5% co 2 in air to establish a pH of 7.4.
Utilizing this medium, Whitten successfully cultured
8-cell mouse PIEs to the blastocyst stage.
By 1957, researchers had been successful in their
efforts to culture a-cell PIEs through the blastocyst

Table 1.

Evolution of media based on Krebs-Ringer bicarbonate for mouse
preimplantation culture.
Modified
Whitten
Brinster
Whitten
M16
BWW
Whitten
1956 1957
1965 1968 1971
1971
1971
1971
1977

BMOC-2
1983

NaCl

X

X

X

X

X

X

X

X

X

X

KCl

X

X

X

X

X

X

X

X

X

X

KH 2 Po 4

X

X

X

X

X

X

X

X

X

X

NaHC0 3

X

X

X

X

X

X

X

X

X

X

Cacl 2

X

X

X

X

MgS0 4

X

X

X

X

Ca Lactate

X
X

X
X

X

X

X
X

X

X

X

X

Na Lactate

X

X

X

X

X

X

X

X

Na Pyruvate

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

Glucose

X

X

BSA

X

X

X

X

X

X

X

X

X

X

Penicillin

X

X

X

X

X

X

X

X

X

X

Streptomycin

X

X

X

X

X

X

X

X

X

X

X

X

EDTA

..,I-'
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stage.

Attempts to culture 2-cell and 4-cell PIEs had

failed (Whitten, 1956a).

To address this problem,

Whitten altered the Krebs-Ringer bicarbonate solution by
substituting calcium lactate (a non-deliquescent
substance) for calcium chloride (a very deliquescent
substance).

Using the new Whitten's Medium, Whitten

(1957a) successfully cultured 2-cell PIEs to the
blastocyst stage (Table 1).

Other modifications in

Whitten's Medium have been made by different researchers,
as a result of the success in culturing 2-cell PIEs
(Biggers, 1987).
In an effort to generate an enhanced Whitten's
Medium, Brinster (1965a,b, and c) conducted a series of
culture experiments using 2-cell PIEs.

Initially,

Brinster (1965b) studied concentration response curves to
identify the optimum osmolarity required to support
embryonic development.

The study resulted in changes in

the medium involving the addition of sodium lactate, the
removal of glucose, and a return to the original KrebsRinger bicarbonate solution (with calcium chloride).
Whitten (1957a) had reported that metabolic
intermediates might be beneficial in culturing PIEs.
Considering this possibility, Brinster (1965c)
investigated the role of intermediates of the EmbdenMeyerhoff pathway and the citric acid cycle at carrying
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concentrations.

He determined that pyruvate, phosphoenol

pyruvate, and oxaloacetate could be substituted for
lactate to enhance the culture of 2-cell PIEs into the
blastocyst stage.
Following his work on metabolic intermediates,
Brin~ter (1965b) experimentally determined that lactate
and pyruvate had a joint effect on development.
Brinster's study demonstrated that low concentrations of
pyruvate enhanced the developmental response of PIEs to
lactate.

Due to the succession of modifications in

Whitten's Medium, as reported by Brinster (1965a, b, and
c), the "new" medium was referred to as Brinster's Medium
(Table 1).

Two-cell PIEs cultured in Brinster's Medium

would develop to the blastocyst stage with an enhanced
rate of viability, when compared to viability using
Whitten's original medium.

Blastocysts transferred to

recipient female mice developed into normal adults.
Brinster's Medium was further modified when it was
noted that the availability of three carbon sources
(pyruvate, lactate and glucose) within the medium were
advantageous to embryonic development (Biggers and
Brinster, 1965),·

The addition of the three energy

sources, at different concentration levels, resulted in
the development of numerous modifications of Brinster's
Medium (Table 1):

(1)

a modified Brinster's Medium
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(Brinster, 1971);
1971);

(3)

(2)

a new Whitten's Medium (Whitten,

M16 Medium (Whittingham, 1971);

Medium (Biggers, et al., 1971);

and

(5)

(4)

BWW

BMOC-2 Medium

(Ebert and Brinster, 1983).
Various researchers had noted that the successful
culturing of one-cell embryos was dependent upon the
mouse strain used in PIE studies;

some one-cell embryos

would not culture beyond the 2-cell stage.

This 2-cell

block phenomenon would allow 1-cell embryos to complete
the first cleavage division, but the embryos would not
progress to the 4-cell stage in culture (Cole and Paul,
1965).

Whitten and Biggers (1968) determined the 2-cell

block phenomenon to be geneticly dependent;

some mouse

strains could not be cultured, unless 2-cell PIEs were
present at recovery.

Abramczuk, et al.

(1977), working

with Whitten's new medium, determined that the addition
of ethylenediaminetetraacetic acid (EDTA) would allow all
one-cell mouse embryos to complete development to the
blastocyst stage.

EDTA has the ability to chelate

divalent cations, an action essential to the development
of l~celled embryos.

The addition of EDTA to Whitten's

new medium enhances the versatility of the culture medium
for PIE culture.

This modification is widely used by

researchers, and is commonly called Whitten's Modified
Medium (Table 1).
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Initiation of the Embryonic Genome

.The development of molecular techniques provided
researchers the opportunity to perform biochemical
analysis of mammalian embryos to better understand the
control mechanisms for early embryogenesis (Epstein,
1975).

During oogensis, oocytes were shown to accumulate

a large volume of maternal macromolecules that resulted
in a 350-fold increase in oocyte size (Magnuson and
Epstein, 1987).

Maternal macromolecules accumulated

included all classes of RNA, and a variety of proteins.
The end of the growth phase was marked by a decline in
RNA synthesis to an undetectable level.

The mature

oocytes contained sufficient RNA for the synthesis of
proteins through the 2-cell stage, following
fertilization (Chen, et al., 1980;

Schultz, 1986;

Magnuson and Epstein, 1987).
Synthesis and modification of proteins during oocyte
maturation, fertilization, and the first cleavage
division (2-cell stage) resulted in various protein
patterns, as determined by electrophoretic studies
(Braude, et al., 1979;

Howlett and Bolton, 1985).

studies have shown that variations in protein patterns,
from oocyte maturation through fertilization, were
intrinsically regulated as a result of post-translational
modifications of pre-existing proteins (Van Blerkom,

17

1981a and 1985;

Van Blerkom and Runner, 1984).

Changes

in the protein patterns, from fertilization through the
2-cell stage, resulted from the occurrence of protein
synthesis utilizing maternally-derived mRNA's
(Van Blerkom, 1981a and 1985;

Van Blerkom and Runner,

1984) .
Several published reports have concluded that
initiation of the expression of the embryonic genome
occurs late in the 2-cell stage and continues through
development; the genome replaces the influence of the
maternal mRNA in the synthesis of proteins.

Dramatic

changes in protein synthesis occurred following the first
cleavage division.

Prior to the second cleavage

division, there was a 6- to 8-fold increase in protein
synthetic activity, which was attributed to the
initiation of the embryonic genome (Schultz, 1986).
Schuitz

confirmed that the control of early embryo-

genesis, through the 2-cell stage, was regulated by
macromolecules accumulated during oocyte maturation.
Using data reported by other researchers, Schultz
supported his conclusions concerning the control of early
embryogenesis.

From fertilization through the 2-cell

stage, PIEs lose 70 - 90% of their maternal mRNA
(Giebelhaus, et al., 1983), and the·synthesis of proteins
has been shown to remain at a constant rate (Brinster, et
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al., 1976).

Within the first 24 hours following

fertilization, 40% of the bulk maternal RNA (Bachvarova
and DeLeon, 1980), 70% of the total polyadenlyated RNA
(Levey, et al., 1978;

Piko and Clegg, 1982), and

approximately 90% of the histone mRNA (Graves, et al.,
1985) and actin mRNA (Giebelhaus, et al., 1985) had been
degraded.

Levels of RNA synthesis were reported to be

low in fertilized ova, but the lowered levels were
followed by a rapid increase in the synthesis of all RNA
classes by the late 2-cell stage (Young, et al., 1978;
Pike and Clegg, 1982;

Clegg and Piko, 1983a, and b).

Earlier, Moore (1975) reported the absence of detectable
RNA polymerase in embryos prior to the attainment of the
2-cell stage.

Further evidence to support Schultz's

conclusion were manifest in reports that changes in the
protein pattern, from fertilization through the 2-cell
stage, were either post-transcriptional modifications of
proteins or the result of protein synthesis utilizing
maternally-derived mRNA's (Braude, et al., 1979;
Petzoldt, et al., 1980;

Van Blerkom, 1981a and 1985;

Van Blerkom and Runner, 1984).

Using transcriptional

inhibitors, such as a-amanitin and actinomycin D, Golbus,
et al.

(1973) and Warner and Versteegh (1974)

demonstrated that early embryos were inhibited in their
development beyond the 2-cell stage.

The final evidence

19

offered in support of Schultz's conclusion, concerning
embryonic genomic expression, involved the use of two
protein genetic variants, ~-glucoronidase (Wual and
Chapman, 1976) and ~2 -microglobulin (Sawicki, et al.,
1982), to detect paternal gene expression in 2-cell
embryos.

This genetic evidence was significant because

it was known that spermatozoa did not contribute rnRNA to
the developing embryo.

Schultz (1986) concluded that the

combination of biochemical and genetic observations
supported the idea that the transition from maternal
control to embryonic genomic control occurs in the 2-cell
stage.
In contrast to the idea that embryonic genomic
expression was initiated at the 2-cell stage, Renard, et
al.

(1991) proposed that embryonic genomic expression was

not required until the 8-cell stage.

This proposal was

based on evidence obtained by using reconstituted embryos
from parthenogenetic and androgenetic blastomeres, fused
together at the 4-cell stage, to produce living mice.
These data suggested that expression of the paternal
genomes were delayed until completion of the second
cleavage division.
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Steroid Influence

The development of culturing procedures for preimplantation mouse embryos has demonstrated that viable
embryos can be maintained through progressive stages of
early embryogenesis in a simple-defined medium (nonphysiological), such as Whitten's Modified Medium.
studies have shown that culturing procedures used for PIE
research cause in vitro maintained embryos to lag
developmentally behind embryos maintained in vivo (Bowman
and McLaren, 19.70a and b;

Spielmann, et al., 1980).

This lag in development has been attributed to the
absence of developmental influencing factors, present
within the maternal reproductive tract, that enhance
early embryo proliferation among in vivo embryos.
Schultz (1986) has shown that early mammalian
embryogenesis was highly dependent on the embryonic
genome for the initiation of rapid cell proliferation and
the onset of differentiation.
Developmental influencing factors investigated for
regulatory enhancement were hormones and unlimited
supplies of energy.

Hormonal influence has been the most

widely studied of the factors thought to play a role in
regulation of embryonic development.

These studies

focused on two aspects of hormone regulation:
(1)

exogenous steroid hormone influence (Warner and
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Tollefson, 1977 and 1978), and

(2)

embryonic

steroidogenesis (endogenous) (Dickmann, et al., 1976 and
1977; Sengupta, et al., 1977).
Whitten (1956b and 1957b) studied the effects of
progesterone on mouse blastocyst in vitro development in
8-cell PIEs.

Whitten's data showed that low

concentrations of progesterone were not inhibitory to
blastocyst development, but progesterone concentrations
of 4µg/ml, and above, were toxic (cleavage inhibition).
Included in these studies were efforts to determine the
presence of antagonistic properties of estrogen in
progesterone treated 8-cell PIEs.

Whitten (1957b)

reported that estrogen did not provide 8-cell PIEs
protection against the toxic effects of progesterone.
Using the rabbit model, Daniel and Levy (1964)
exposed PIEs to various progesterone concentrations to
determine the inhibitory effects of progesterone on PIEs.
These investigations demonstrated that progesterone
levels of lOµg/ml and above, inhibited cleavage up to the
blastocyst stage.

However, blastocysts treated with

progesterone did not exhibit inhibitory responses.

It

was demonstrated that PIE cleavage, inhibited by
progesterone, would recover from the cleavage block when
transferred to a medium lacking progesterone.

These data

suggested that progesterone inhibition resulted from
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interference with the supply of essential amino acids, or
proteins, to pre-blastocyst PIEs.

Progesterone

aggregation was believed to occur at the zona pellucida
or on the ovum surface.
Daniel (1964) reported that estrogen caused the
formation of small cytoplasmic protrusions (blebs) on
rabbit PIEs.

The blebs lacked an organized nucleus and

contained small amounts of chromosomal material.

The

formation of the blebs resulted from excessive
subdivisions of the PIEs at a time when the nuclear
material was mitotically reorganizing into chromosomes.
Excessive subdivisions resulted in the inability of the
blastomeres to distribute their nuclear material equally
during cleavage.
Studies involving the culture of mouse PIEs, 2-cell
through the blastocyst stage, in the presence of 25µg/ml
of 17-~-estradiol, or 8µg/ml of progesterone, were
conducted by Kirkpatrick (1971).

In this report,

Kirkpatrick concluded that differential sensitivity
indicated a definite trend toward resistance to the
inhibitory effects of steroids as early PIEs progressed
through development.
The influence of 17-~-estradiol on the uptake of
amino acids and their incorporation into proteins by
2-cell mouse PIEs cultured through blastocyst hatching
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was reported by Smith and Smith (1971).

Early

blastocysts showed a slight increase in amino acid uptake
and in the incorporation of amino acids into proteins.
Expanded blastocysts were observed to have a
significantly higher amino acid uptake and protein
incorporation.

Hatched blastocysts (expanded blastocysts

following the rupture of the zona pellucida) had the
ability to uptake amino acids, but incorporation of amino
acids into proteins was not detected,

These data

demonstrated that 17-~-estradiol directly influenced the
preimplantation blastocysts in the uptake of amino acids.
In addition, it was suggested that hatched blastocysts
developed an estrogen-sensitive mechanism prior to
implantation.

In a related study using rabbit PIEs,

El-Banna and Daniel (1972) reported that low concentrations of progesterone were essential to blastocyst
development when cultured in a simple-defined medium,
supplemented with macromolecular serum components.

In

this study, amino acid uptake was enhanced and embryo
viability was improved.

El-Banna and Daniel (1972)

speculated that incorporated proteins acted as
progesterone carriers.
Investigations have shown that non-steroidal
antiestrogens prevent estrogens from expressing their
effects on target tissues (Clark, et al., 1973;
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Katzenellenbogen, et al., 1979).

Estrogen antagonists,

such as nafoxidine (Ull,lOOA) and CI-628, compete with
17-~-estradiol for specific binding sites on the same
receptor.

These antiestrogens were reported to cause the

retention of estrogen receptors in rat uterine nuclei
(Clark, et al., 1973 and 1974;
Katzenellenbogen, 1977).

Ferguson and

The retention of the estrogen

receptor stimulated uterine growth but inhibited the
replacement of cytoplasmic receptors.

This inability to

stimulate the replacement of cytoplasmic receptors
demonstrated the antagonistic properties of the nonsteroidal antiestrogens.

The mechanism of action for

estrogen and the inhibition by estrogen antagonists are
illustrated in Figure 3.

Due to the lipophilic nature of

these molecules, the receptor recognition occurs within
the cell boundary.

Engagement of the estrogen receptor

complex induces specific genomic sites to synthesize RNA
and, subsequently, protein synthesis.

The antagonists

prevent this action by estrogen.
Warner and Tollefson (1977 and 1978), working with
a-cell and blastocyst mouse embryos, reported that RNA
synthesis was not influenced by exogenously administered
physiological concentrations (l0- 5 M - l0- 9 M) of
17-~-estradiol, progesterone, or combined
17-~-estradiol/progesterone.

Included in this study were
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Figure 3. Schematic representation of estrogen's
mechanism of action (Mendelson, 1988). S=ligand,
R=receptor.
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both short-term and long-term incubation periods (0.5-24
hours) to determine the occurrence of primary and/or
secondary effects on RNA synthesis.

Increased

stimulation of RNA synthesis was observed when PIEs were
exposed to 15% heated mouse serum.

Following exposure to

heated mouse serum, PIEs treated with progesterone were
inhibited in the synthesis of RNA.
Whitten's Medium was shown to be a highly effective
medium for the culture of 8-cell rat PIEs to the expanded
blastocyst stage (Roy, et al., 1981).

Data showed that

blastocyst formation was severely reduced when 3µg/ml of
nafoxidine was added to Whitten's Medium.

Administration

of lµg/ml of 17-~-estradiol to nafoxidine treated 8-cell
PIE cultures did not reverse the developmental inhibition
of nafoxidine.

Early blastocysts, supplemented with

lµg/ml of 17-~-estradiol, following culture in 3µg/ml of
nafoxidine resulted in a 60% reversal in blastocyst
expansion (Sengupta, et al, 1982).

These data

demonstrated that 17-~-estradiol reversed the
antiestrogenic response induced by nafoxidine in
blastocysts.
Overall, investigations concerning the influence of
exogenously administered steroid hormones on protein
synthesis and RNA synthesis, using in vitro cultured
PIEs, have provided little evidence to support the id.ea
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that maternally derived hormones directly influence early
embryogensis.

The paucity of evidence supporting direct

maternal hormonal influence initiated investigations into
the role of the embryo in endogenous steroid hormone
production.

Developmental activities related to the

transformation of the morula to a blastocyst, as
influenced by embryo steroidogenesis, were investigated
by Dickmann, et al.

(1976) and Sengupta, et al.,

(1977).

Transformation of the morula to the blastocyst, a
significant event in PIE development, was considered to
be estrogen/progesterone dependent.
Dey and Dickmann (1974) demonstrated that mouse PIEs
possessed the steroidogenic enzymes A5 -3-~-hydroxysteroid
dehydrogenase (3~-HSD) and 17-~-hydroxysteroid
dehydrogenase (17~-HSD).

This report suggested that PIEs

had the ability to endogenously produce steroid hormones.
The enzyme activity of 3~-HSD was reported in 30% of the
2-cell PIEs (Dey and Dickmann, 1974), and 17~-HSD was
present in 2-cell PIEs (Dickmann, et al., 1976).
Steroidogenic enzyme activity in early PIEs has been
reported for other models:

the hamster model (Dickmann

and Sengupta, 1974), the rat model (Dickmann and Dey,
1974), and the rabbit model (Dickmann, et al. 1975).
Progesterone and 17-~-estradiol were reported as being
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present in mouse blastocysts using radioimmunoassay
techniques (Dickmann, et al., 1975 and 1976).
Using the antiestrogen CI-628, Sengupta, et al.
(1977) reported that PIEs were inhibited in their
formation to blastocysts from morulas.

The addition of

17-~-estradiol allowed cultured morulas to progress to
the blastocyst stage (Sengupta, et al., 1977, 1982, and
1983).

These data suggested that endogenous estrogen in

PIEs played a critical role in morula-blastocyst
transformation (Faria, et al., 1984).

Tamoxifen

Recent reports suggest that a new non-steroidal
agent, tamoxifen ([Z]-2-[4-(l,2-Diphenyl-l-butenyl)phenoxy]-N,N-Dimethylethanamine), possesses potent
antiestrogenic properties (Patterson, 1981).
Antiestrogenic effects were a direct result of
tamoxifen's ability to compete with estrogen for
available binding sites in target tissues.

Competition

for available binding sites was reported to prevent the
estrogen-receptor complex from forming specific
associations with the nuclear acceptor sites.

The

formation of a tamoxifen receptor complex which directly
associates with the embryonic genome fails to stimulate
transcription (Jordan and Murphy, 1990).
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Two-Dimensional Electrophoresis

The utilization of two dimensional (2-D) gel
elec~ropheresis, has provided researchers a method for
the isolation and characterization of polypeptides.
Because 2-D electrophoresis provides accurate resolution
of polypeptides from a relatively small volume of
experimental material, 2-D studies have been shown to be
applicable to the study of early embryonic development.
The number of mouse embryos used in two dimensional
studies (2-D gels) has varied from 15 (Poueymirou et al.,
1989) to 150 PIEs (Van Blerkom, 1981a).

Analyses of the

changing pattern of protein composition in various PIE
stages, through 2-D studies, has generated a protein
profile for early embryogenesis.

Approximately 300

polypeptides have been resolved for mouse PIEs, oocyte
through blastocyst stage (Chen, et al., 1980;
Van Blerkom, 1981a;
et al., 1982;
1985;

Cascio and Wassarman, 1982;

Bolton, et al., 1984;

Flach,

Howlett and Bolton,

Poueymirou and Schultz, 1989).

Hypothesis

This study will attempt to determine the influence
of exogenously administered 17-~-estradiol on in vitro
cultured preimplantation mouse embryos.

Specifically,

this research hypothesizes that 17-~-estradiol enhances
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protein synthesis in 2-cell, 4-cell, and a-cell
preimplantation embryos.

This study will also attempt to

verify the antiestrogenic properties of tamoxifen.
Analysis of 17-~-estradiol enhancement and tamoxifen
inhibition will be determined through comparative studies
of the protein patterns for 2-cell, 4-cell and a-cell
preimplantation embryos as determined through two
dimensional electrophoretic procedures.

CHAPTER II

MATERIALS AND METHODS

Induction of superovulation

Preimplantation embryos (PIEs) were collected from
hormone-stimulated female Swiss Webster albino mice
(Harlan Sprague Dawley, Inc.) that were 4-10 weeks of
age. Mice were maintained under a controlled light regime
in the Morehead state University

Animal Facility.

An

alternating 12-hour light/dark photoperiod was
maintained, with the midpoint of the dark period
occurring at 12:00 a.m.

Mice were fed Purina mouse chow

(Ralston Purina Company) and water ad libitum.
Estrus initiation in the experimental mice was
induced by injecting gonadotropin [pregnant mares' serum
gonadotropin (PMSG)] into the peritoneal cavity (Fowler
and Edwards, 1957;

Gates and Dronkert, 1965).

Female

mice were given intraperitoneal injections of 5
internation~l units (5 IU) of PMSG (Sigma Chemical Co.);
(Warner and Tollefson, 1978;

personal communication:

Reid), in 0.05-cc volume using a 1-cc syringe with a
26 2/3-gauge needle.

PMSG induction was initiated at
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12:00 p.m. for each experimental group to synchronize the
subsequent hCG injections, and the recovery of PIEs
(Figure 4).

Human chorionic gonadotropin (hCG, Sigma

Chemical Co.) injections of

5 IU (Warner and Tollefson,

1978; personal communication: Reid), in 0.05-cc volume
using a 1-cc syringe with a 26 2/3-gauge needle, were
intraperitoneally administered 45 hours post-PMSG
injection (9:00 a.m.).

Following the hCG injection, each

female mouse was placed in a separate breeding cage with
a fertile male.

At 20 hours post-hCG injection (8:00

a.m.r, each female mouse was examined for the presence of
a vaginal plug (sperm plug) to verify copulation
(Poueymirou and Schultz, 1987).
Females with vaginal plugs were separated from males
and maintained in separate cages until the proper time
for the extraction of PIEs.

Those females that failed to

copulate were returned to the colony and again stimulated
with PMSG and hCG, following a waiting period of 7-10
days.

Embryo Recovery

-Preimplantation embryo recovery was made at 45
(2-cell), 54 (4-cell), and 62 (8-cell) hours post-hCG
injection (Brinster, 1965a and 1967;
Tollefson, 1978).

Warner and

Female mice were sacrificed by 5 IU
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5 IU~

5 IU~

Female Mouse-----Female Mouse
45 hrs
12 hrs
Ovulation and Fertilization

2-Cell Stage
(30 hrs)

4-Cell stage
(44 hrs)

a-cell stage
(52 hrs)

Embryo Recovery

Embryo Culture
8 hrs
Viability Observations

Sample Preparation

Two Dimensional Gel Electrophoresis
Figure 4.

outline of laboratory experimentation.
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cervical dislocation and the skin was removed from the
ventral abdominal wall to prevent hair contamination
during oviduct excision.

Skin removal was accomplished

by making a mid-ventral incision the length of the
abdominal cavity, and two lateral incisions below the rib
cage.

sterile forceps were used to retract the skin and

expose the entire abdominal wall.

The viscera were

exposed by making two lateral incisions just anterior to
the posterior legs and continuing along the lateral
abdominal wall to the rib cage.

The muscle flap was

lifted forward between the forelegs to allow gross
observation of the viscera in the lower abdominal cavity.
To expose the uterine horn and oviduct on each side of
the abdominal cavity, the digestive tract and fat
deposits were moved from side to side.
To remove each oviduct, microdissection scissors
were used to bisect the uterine horn anterior to the body
of the uterus.

Watchmaker's forceps were used to grasp

the free end of the uterine horn and lift the oviduct
from the abdominal cavity.

Connective tissue was removed

from the uterine horn, using microdissection scissors.
The oviduct was excised by cutting the bursa at the
ovarian end of the reproductive tract (Schneider, 1970).
Following excision, each oviduct was positioned on a
glass plate flooded with Whitten's Modified Medium
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(Abramczuk, et al., 1977;

Poueymirou, et al., 1989).

A

standard pedestal dissecting microscope (American
Optical: 7-42 zoom) was used to separate each oviduct
from the uterus;

dissection was made at the uterotubal

junction (Weldon, 1971).

Each oviduct was transferred to

a clean pool of Whitten's Modified Medium.

A blunted

JO-gauge needle, attached to a 1-cc syringe containing
Whitten's Modified Medium, was inserted into the
fimbriated end of the oviduct (Lyon, 1971).

The PIEs

were_flushed by gently forcing medium through the oviduct
and embryos were collected in a depression slide
containing culture medium.

PIEs were immediately washed

in two baths of culture medium;

transfers were made

using an Eppendorf micropipetor, set at 2µ1, with a gel
loading tip.

The transfers were designed to wash the

embryos by removing cellular debris (cumulus and red
blood cells) from the culture medium (Brinster, 1967).
Following the second bath, the PIEs were transferred to
culture dishes containing Whitten's Modified Medium, and
placed in an incubator.

Embryo Culture

Preimplantation mouse embryos were recovered and
cultured in Whitten's Modified Medium (Abramczuk, et al.
1977).

The modification of Whitten's Medium (Whitten,
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1971) was made by adding ethylenediaminetetraacetic acid
(EDTA).

The modification was made to utilize the

chelating action of EDTA in the removal of divalent metal
cations (Abramczuk, et al. 1977).
Whitten's Modified Medium (100-ml volumes) was
prepared each week.

The components and concentrations in

Whitten's Modified Medium are shown in Table 2.

Protocol

for medium preparation was according to Whitten (1971),
with the addition of 1ml of a l0mM EDTA solution (l00mM
concentration of EDTA in the medium) prior to the
addition of crystalline bovine serum albumin (Poueymirou
and Schultz, 1989).

The medium was gassed with 5% co 2 in

air (Whitten, 1971), until a pH value between 6.8-7.2 was
obtained (Brinster 1965a).

Following the pH adjustment,

the medium was filtered using a disposable filter
apparatus (Nalge 120 Nalgene, Inc.), with a 0.2 micron
filter (Whitten, 1971).

After filtration, the medium was

transferred to a culture flask, inside a bioflow hood,
and refrigerated at 4°c until it was used.

Fresh culture

medium was prepared weekly.
Prior to sacrificing the mice, portions of the
culture medium were transferred to an incubation chamber
and kept for 30 minutes at 370c in a humid atmosphere of
5% co 2 in air.

This procedure assured that optimal

culture conditions were provided.

The medium was
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Table 2.

Medium Formulation (Whitten, 1971).

Component
NaCl

Concentration/100ml
514.00 mg

KCl

36.00 mg

KH 2 Po 4

16.00 mg

MgSO 4 7H 2 O

29.00 mg

NaHCO 3
Na Pyruvate
Ca Lactate 5H 2 O
Glucose

190.00 mg
3.50 mg
53.00 mg
100.00 mg

K Penicillin G

8.00 mg

streptomycin so 4

5.00 mg

Double Distilled H2 O

100.00 ml

60% Sodium Lactate

0.37 ml

1% Phenol Red

0.10 ml

10mM EDTA

1.00 ml

Bovine Serum Albumin

300.00 mg
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dispensed in 1-ml aliqouts to the center well of an organ
culture dish (15x60, Falcon Plastics).

An additional

10ml of the medium was transferred to a 25-ml Erlenmeyer
flask, and placed in the incubation chamber.

The

additional volume of medium was used for the recovery of
PIEs.
Experimental protocol required the recovery of PIEs
in three different embryonic stages:
(42 hrs post-hCG);
and

(3)

(2)

(1)

2-cell stage

4-cell stage (56 hrs post-hCG);

8-cell stage (64 hrs post-hCG).

After recovery

and preincubation washes, groups of ten embryos for each
developmental stage were transferred to the 1 ml aliquots
of Whitten's Modified Medium in the center well of the
organ culture dishes.

According to the protocol flow

sheet (Figure 4), PIEs were cultured for 8 hours in one
of five treatment groups.

Treatment Group I:

Treatment groups were:

Medium plus lµg 17-~-estradiol

(3.4xl0- 3mM) in 50µ1 absolute ethanol-saline (l.4xl0- 2mM
absolute ethanol; 0.9% NaCl solution);
Treatment Group II:

Medium plus 50µ1 of absolute

ethanol-saline (l.4xl0- 2mM absolute ethanol; 0.9% NaCl
solution);
Treatment Group III:
Treatment Group IV:

Medium only;
Medium plus 3µg tamoxifen;
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Treatment Group V:

Medium plus 3µg tamoxifen and

lµg 17-13-estradiol in 50µ1 absolute ethanol-saline
(l.4xl0- 2mM absolute ethanol;

0.9% NaCl solution).

Steroids and antisteroid solutions for each
treatment group were prepared, as stock solutions, to
permit the direct delivery of each treatment to the
culture dish containing 10 PIEs.

The 17-13-estradiol

stock solution (Sigma Chemical Co.), used in Treatments I
and v, was prepared in absolute ethanol to establish a
lµg/ml (3.6mM) solution (Roy, et al., 1981).

The

concentration of lµg/ml of 17-13-estradiol was selected as
a result of published reports that such treatments would
not have deleterious effects on PIE development (Roy, et
al., 1982;

Warner and Tollefson, 1977).

Following the

preparation of the 17-13-estradiol stock solution, the
solution was diluted with sterile saline (0.9% NaCl)
(Sengupta, et al., 1982) to obtain a 20µg/ml (7.3xl0- 2mM)
17-13-estradiol solution with an ethanol concentration of
4.2xl0- 1mM (Roy, et al., 1982).

A 50µ1 aliquot of the

17-13-estradiol solution was added to the culture dishes
containing 10 PIEs for Treatments I and V.

Treatment

concentration within the culture medium was lµg for
17-/3-estradiol (3.4xl0- 3mM) and l.4xl0- 2mM concentration
of ethanol (Roy, et al., 1982).
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Treatment II was identical to Treatment I, except
17-~-estradiol was not added to the stock solution.
Because the 17-~-estradiol used in Treatment I was
ethanol soluble, Treatment II was necessary to
differentiate between the effects of ethanol and
17-~-estradiol.
Preimplantation embryos in Treatment III were
maintained in Whitten's Modified Medium to serve as an
experimental control.
The tamoxifen (Sigma Chemical Co.) stock solution
was prepared by dissolving 1mg of tamoxifen in 50µ1 of
absolute ethanol, and the volume was increased to 1ml
with sterile saline.

The addition of sterile saline

produced a lµg/ml tamoxifen solution for use in
Treatments IV and v.

Tamoxifen, a non-steroid estrogen

blocker, was used in Treatment IV as the only variable to
determine its effects on PIEs.

Three microliters of the

tamoxifen solution (3µg) were added to the culture dishes
used in Treatment IV.

Tamoxifen treatments of 3µg/ml

were derived from published reports for the antiestrogen
nafoxidine (Ull, l00A).

Roy, et al. (1981) demonstrated

that 3µg/ml of nafoxidine was effective in the inhibition
of blastocyst expansion in mouse PIEs.
Embryos cultured in Treatment V were exposed to both
tamoxifen and 17-~-estradiol.

Following the transfer of
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the embryos to the culture dishes, 3µ1 of the tamoxifen
solution (Jµg) was added to Treatment v.

Fifteen minutes

after the beginning of the incubation period, 50µ1 of the
17-~-estradiol solution was added to the culture dishes
in Treatment V.

Delayed administration of 17-~-estradiol

permitted tamoxifen sufficient time to bind estrogen
receptors.
Culture experiments using 2-cell, 4-cell and a-cell
PIEs -were conducted in units of 10 embryos with 6
replicas for each treatment group;

60 PIEs were cultured

per treatment group for each embryonic stage.

Randomized

replicas were conducted to increase sample size and to
minimize the effects of systemic errors.
For Treatment Groups I, II, IV and V, the addition
of steroids and antisteroid solutions immediately
followed the transfer of 10 PIEs to culture dishes.
Incubation was maintained for a hours at 37°c in an
atmosphere of 5% co 2 in air.

At the conclusion of the

eight-hour incubation period, PIEs were then examined for
viability.

Viability was determined by progression of 2-

cell, 4-cell and a-cell PIEs to 4-cell, a-cell, and
morula stages, respectively.

PIEs that failed to advance

during the culture period were inhibited in their
development by a treatment or they were inviable.
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PIEs recovered were transferred, as a group of 10,
to 1.5-ml microfuge tubes containing 10µ1 of triton-X-100
sample buffer (lysis buffer) (O'Farrell, 1975).

The

microfuge tubes were stored at -7o 0 c for later analysis.
To determine significance between PIE treatment
groups, the standard normal z-statistic was used at
p<0.05.

Two-Dimensional Gel Electrophoresis

Treatment Groups I-V of frozen preimplantation mouse
embryos, were prepared for analysis by two-dimensional
(2-D) gel electrophoresis.

Resultant 2-D gels would

provide individual protein profiles for the various
treatment groups.
Sample preparation was effected in lysis buffer, and
involved a series of freeze-thaw cycles to enhance cell
lysis and the suspension of the polypeptides in solution.
Lysis was followed by centrifugation for 15 minutes at
14,000 rpm.

Three preimplantation embryo samples, each

containing 10 solubilized embryos, were combined for
electrophoretic studies; 30 treated PIEs per gel
(Poueymeitou, et al., 1989).

condensed samples were

frozen at -7o 0 c and, prior to use, were cycled through a
freeze~thaw process and centrifuged for 15 minutes at
14,000 rpm with a Eppendorf Model 5415 Microcentrifuge
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(Brinkmann).

Following polypeptide suspension, samples

were subjected to 2-D gel electrophoresis according to
the method described by O'Farrell (1975), and revised by
Dunn and Burghes (1983a and b).
·Isoelectric focusing (IE_F) constituted the first
dimension of 2-D electrophoresis.

During IEF,

po_lypeptides were separated on the basis of their
isoelectric points.

IEF of PIE samples was performed

using ampholytes with a pH range of 5 to 7 and 3.5 to 10
(Pharmacia, LKB) in 1.0mm inner diameter tubes.

Tube gel

electropheresis was run at 400 volts for 12 hours.

The

limit values of the pH gradient were 4.65 and 9.60 as
determined by IEF standards (Bio Rad).
Following IEF, the tube gels were placed on top of
SDS polyacrylamide gels, which included a 4% stacking gel
and a 10% resolving gel.

In the second dimension, the

poly-peptides were separated on the basis of their
molecular weights.

O'Farrell's (1975) procedure was

modified by substituting diacylylpiperazine (PDA;
BioRad) for bis-acrylamide as the cross-linker in
SDS-PAGE (Hochstrasser, et al., 1988).

Following 2-D gel

electrophoresis, the gels were silver stained according
to the method of Wray, et al. (1981), and a polypeptide
map was constructed at each embryonic stage.

Individual
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proteins were characterized according to their molecular
weight and apparent isoelectric (pI) values.

CHAPTER III

RESULTS

Viability Data

Preimplantation embryos were examined for viability
following the 8 hour incubation period.

Cultured embryos

for each treatment group were observed to determine the
occurrence of cleavage during incubation.

Data obtained

for 2-cell PIEs incubated for 8 hours in Whitten's
Modified Medium are presented in Table 3 by treatment
group.

Control Treatment Groups II (ethanol~saline) and

III (medium control) yielded 76.6% and 80% progression to
the 4-cell stage following incubation.

Thus, the

addition of 50µ1 of ethanol-saline to Whitten's Modified
Medium was without effect.

Therefore, Treatment Group II

was used in all viability comparisions as the
experimental control.
PIEs in Treatment Group I were incubated in the
presence of 17-~-estradiol.

Following incubation, 11 of

60 (18.3%) of the PIEs had advanced to the 4-cell stage,
a significant (p<0.05) reduction in embryonic progression
as compared to the experimental control.

In Treatment

Group IV, PIEs were cultured in the presence of tamoxifen
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Table

3.

Interaction of 17-B-estradiol and tamoxifen on the progression of
2-cell mouse preimplantation embryos in vitro culture for 8-hours.

Concentration
of
Experimental No. of Drug/Vehicle
Group
Schedule
Replica
per ml

Total No.
of
2-Cell
Embryos
Cultured

Total No.
of
Advancing
2-Cell Embryos

% of 2-Cell
Embryos
Advancing
after 8 hours
Culture

I

17-B-Estradiol

6

lug

60

11a,b

18.3

II

Ethanol-Saline

6

50ul

60

46

76.6

III

Medium Control

6

60

48

80.0

IV

Tamoxifen

6

3ug

60

49

81. 6

V

Tamoxifen +
17-B-Estradiol

6

3ug + lug

60

25a

41. 6

~Significant at p < .05 from control group II
Significant at p < .05 from treatment group V
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and al.6% advanced to the 4-cell stage, a value similar
to that of the experimental control.

Embryos cultured in

Treatment Group V were exposed to both tamoxifen and
17-~-estradiol.

Following incubation, 41.6% of the PIEs

advanced to the 4-cell stage, a significant (p<0.05)
decrease from the experimental control.

When Treatment

Group V was compared to Treatment Group I, there was also
a significant (p<0.05) increase in the number of PIEs
progressing to the 4-cell stage suggesting a possible
block of 17-~-estradiol by tamoxifen.
Data obtained for 4-cell PIEs incubated for a hours
in Whitten's Modified Medium are presented in Table 4 by
treatment group.

Control Treatment Groups II (ethanol-

saline) and III (medium control) both yielded 70%
progression to the a-cell stage following incubation.
PIEs in Treatment Group I, incubated in the presence
of 17-~-estradiol, showed that 70% of the PIEs had
advanced to the a-cell stage.

The 17-~-estradiol

treatment produced results equal to that of the
experimental control (Group II).

In Treatment Groups IV

(tamoxifen only) and V (tamoxifen plus 17-~-estradiol),
11 of 60 PIEs (la.3%) advanced to the a-cell stage, a
significant (p<0.05) decrease from the experimental
control.

Thus, tamoxifen by itself or in the presence of

Table

4.

Interaction of 17-B-estradiol and tamoxifen on the progression of
4-cell mouse preimplantation embryos in vitro culture for 8-hours.

Concentration
of
Experimental No. of Drug/Vehicle
Group
Schedule
Replica
per ml

Total No.
of
4-Cell
Embryos
Cultured

% of 4-Cell
Total No.
of
Advancing
4-Cell Embryos

Embryos
Advancing
after 8 hours
Culture

I

17-B-Estradiol

6

lug

60

42

70.0

II

Ethanol-Saline

6

soul

60

42

70.0

III

Medium control

6

60

42

70.0

IV

Tamoxifen

6

3ug

60

lla

18.3

V

Tamoxifen +
17-B-Estradiol

6

3ug + lug

60

lla

18.3

asignificant at p < .05 from control group II
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17-~-estradiol, was effective in reducing viability at
the 4-cell stage.
Data obtained for a-cell PIEs incubated for a hours

in Whitten's Modified Medium are presented in Table 5 by
treatment group.

control Treatments Group II (ethanol-

saline) and III (medium control) yielded a6.6% and a5%
progression to the morula stage following incubation.
Again, Treatment Group II was used as the experimental
control.
'Following incubation, in the presence of 17-~estradiol (Group I), al.6% of the PIEs had advanced to
the morula stage;

results that were similar to that of

the experimental control.

In Treatment Group IV, PIEs

cultured in the presence of tamoxifen showed that only 17
of 60 (2a.3%) advanced to the morula stage, a significant
(p<0.05) reduction in embryonic progression as compared
to the experimental control.

Nineteen of 60 (31.6%)

embryos exposed to both tamoxifen and 17-~-estradiol
(Group V), advanced to the morula stage, a significant
(p<0.05) decrease from the experimental control.

Again,

as was evident at the 4-cell stage, tamoxifen blocked or
retarded the cleavage in a-cell PIEs.

Table

5.

Interaction of 17-B-estradiol and tamoxifen on the progression of
a-cell mouse preimplantation embryos in vitro culture for 8-hours.

Concentration
of
Experimental No. of Drug/Vehicle
Group
Schedule
Replica
per ml

Total No.
of
8-Cell
Embryos
cultured

Total No.
of
Advancing
8-Cell Embryos

% of 8-Cell
Embryos
Advancing
after 8 hours
Culture

I

17-B-Estradiol

6

lug

60

49

81.6

II

Ethanol-Saline

6

50ul

60

52

86.6

III

Medium Control

6

60

51

85.0

IV

Tamoxifen

6

3ug

60

17a

28.3

V

Tamoxifen +
17-B-Estradiol

6

3ug + lug

60

19a

31. 6

asignificant at p < .05 from control group II

U1

0
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Electrophoretic Data

Comparative studies of the protein content in
2-cell, 4-cell and a-cell cultured PIEs were conducted
using high-resolution, two-dimensional polyacrylamide gel
electrophoresis.

Protein profile maps for Treatment

Groups II (ethanol-saline) and III (medium control), were
determined to be equal within each embryonic stage
(2-cell, 4-cell, and a-cell).

Because Treatment Group II

was considered as the experimental control for the
viability studies, comparisons of protein profiles
between treatment groups were made using the polypeptide
map of this treatment group at each stage.

The 2-D gel

and polypeptide map for Treatment Group II resulted in
the identification of n- proteins and each was assigned a
number.

Additional proteins characterized in Treatment

Groups I, IV, and V, but not found in Group II, were
assigned letters.
Protein profiles for 2-cell PIEs, as a result of 2-D
gel electrophoresis, are presented in Figures 5 - 8.

The

2-D gel and polypeptide map for Treatment Group II
resulted in the identification of 57 proteins (Figure 5).
Treatment Group I, 2-cell PIEs incubated in the
presence of 17-~-estradiol, yielded a polypeptide map
with 57 proteins (Figure 6).

Proteins 15, 47 - 49 and 50

were absent in Treatment Group I.

Proteins A - E were
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(Treatment Group IV). Thirty PIEs were loaded on to the
gel. The upper panel is a silver stained 2-D gel and the
lower panel is a polypeptide map in which numbers or
letters have been assigned to represent each silver
stained spot. The labeled polypeptides were tabulated in
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stained 2-D gel and the lower panel is a polypeptide map
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Table 6.

Characteristics of 2-cell preimplantation
embryos separated by two-dimensional
polyacrylamide gel electrophoresis. #1:
ethanol-saline control, #2: 17-~-estradiol,
#3: tamoxifen, #4: tamoxifen + 17-~-estradiol.
Protein's Presence (+)
pr Absence(-) in gels
MW

Spot#
1
2
3
4
5
6
7
8
9

10
11
12
13
14
15
16
17
18
19

20
21
22

23
24
25
26
27
28
29

30
31
32
33

34
35
36
37

(kDal

106
106
105
107
107
104
104
105
105
105
95

104
90
87
94

92

87
85

101
101
94

Apparent
pJ_

>9.6
>9.6
9.2
8.7
8.4
8.1
7.8

7.5
7.2
6.9
>9.6
8.7
9.0
9.0
7.9
7.9
7.7
7.7
6.7
6.3
6.0

89
84
81

5.9
6.8

79
73
81
79
79
76
75
76
75
76
71
66

5.9
5.9
9.0
9.0
8.1
8.3

7.9
7.5
7.3
6.9
6.4
7.2
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8.8

6.0

ll

li

ll

li

+
+

+

+

+
+
+
+
+
+

+

+
+

+

+

+

+
+

+

+
+
+

+
+

+
+
+

+
+
+

+

+

+
+

+

+

+
+

+
+
+
+

+

+

+

+
+

+
+

+

+

+

+

+
+

+
+

+

+
+

+
+
+
+
+
+
+
+
+
+
+
+
+

+
+

+
+
+
+

+

+

+
+

+
+

+

+

+

+

+
+

+
+
+
+
+

+
+

+
+
+

+
+
+

+

+

+
+
+
+
+

+
+

+

+
+
+

+

+
+

+
+

+

+

+
+
+

+

+

+
+
+
+

+
+
+

+
+

+
+
+
+
+
+

+
+
+
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Table 6.

Continued.

MW

Spot j/
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
A
B

C
D
E
F
G

H

(kDa)
56
61
62
63
60
69
64
51
47
53
50
52
49
51
36
45
48
51
52
34
102
80
76
60
42
>31
72
37

Apparent

Pl.
8.8
7.8
7.3
7.0
6.6
<4.65
4.6
9.1
9.1
7.8

a.a

7.8
7.7
7.0
7.4
6.3
6.2
5.8
4.9
4.7
9.3
6.2
5.7
8.5
5.3
5.9
6.9
8.9

Protein's Presence (+)
or Absence C-l in gels

ll
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

n
+
+
+
+
+
+
+
+
+

ll

li

+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+
+
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present in Treatment Group I, but absent in Treatment
Group II.
Tamoxifen supplemented 2-cell PIEs in Treatment
Group IV generated a polypeptide map composed of 56
proteins (Figure 7).

Proteins 47 - 50 and 52 were

absent, however, proteins B - D, and F were present in
Treatment Group IV •
.Treatment Group v, supplemented with tamoxifen and
17-~-estradiol, produced a polypeptide map identifying 58
proteins (Figure 8).

Proteins 44, 47, 49, 50, and 57

were absent, however, proteins A - D, G, and H were
present in Treatment Group V.

Data for 2-D gel electro-

phoresis on all 2-cell PIEs are presented in Table 6.
Protein profiles for 4-cell PIEs are shown in
Figures 9 - 12.

The 2-D gel and polypeptide map for

Treatment Group II produced a total of 71 proteins
(Figure 9).
Treatment Group I, 4-cell PIEs incubated in the
pres~nce of 17-~-estradiol yielded a polypeptide map with
69 proteins (Figure 10).
absent.

Proteins 2, 3, and 53 were

Protein A was present in Treatment Group I, but

absent in Treatment Group II.
Tamoxifen supplemented 4-cell PIEs, Treatment Group
IV, generated a polypeptide map composed of 45 proteins
(Figure 11).

Proteins 11 - 15, 17, 18, 21, 23, 24, 27,
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Figure 9. Two-dimensional gel electrophoresis of 4-cell
PIEs incubated in the ethanol control (Treatment Group
II). Thirty PIEs were loaded on to the gel. The upper
panei is a silver stained 2-D gel and the lower panel is
· a polypeptide map in which numbers or letters have been
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labeled polypeptides were tabulated in Table 7 for their
MW and apparent pr values.
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Figure 10. Two-dimensional gel electrophoresis of 4-cell
PIEs incubated in the presence of lµg of 17-~-estradiol
(Treatment Group I). Thirty PIEs were loaded on to the
gel. The upper panel is a silver stained 2-D gel and the
lower panel is a polypeptide map in which numbers or
letters have been assigned to represent each silver
stained spot. The labeled polypeptides were tabulated in
Table 7 for their MW and apparent pI values.
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Figure 11. Two-dimensional gel electrophoresis of 4-cell
PIEs incubated in the presence of 3µg of tamoxifen
(Treatment Group IV). Thirty PIEs were loaded on to the
gel. The upper panel is a silver stained 2-D gel and the
lower panel is a polypeptide map in which numbers or
letters have been i;tssigned to represent each silver
stained spot. The labeled polypeptides were tabulated in
Table 7 for their MW and apparent pI values.
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Table 7. Characteristics of 4-cell preimplantation
embryos separated by two-dimensional
polyacrylamide gel electrophoresis. #1:
ethanol-saline control,
#2: 17-~-estradiol,
#3: tamoxifen, #4: tamoxifen + 17-~-estradiol.
Protein's Presence(+)
pr Absence C-l in gels
MW

Spot j/

(kDal

1

111

2
3

106
105
107
104
102
102
103
104
105
98
98
96
96
98
93
92
90
81
83
91
92
91
92
81
95
92
95

4
5
6
7
8
9

10
11
12
13
14
15
16

17
18
19
20
21
22
23
24
25
26
27
28
29

30
31
32
33

34
35
36
37

94

91
90
90
83
82
80
75
73

Apparent

Pl.
>9.6
>9.6
9.2
8.7
8.3
8.0
7.7
7.4
7.2
7.0
9.2
9.0
8.9
8.7
8.6
8.1
8.3
8.3
8.0
7.7
7.7
7.3
7.4
7.2
7.0
6.6
6.6
6.2
6.0
6.0
6.4
6.3
5.8
6.0
6.7
6.1
5.9

ll

ll

ll

li

+
+
+
+
+
+

+

+
+

+
+

+
+

+
+

+
+
+

+

+

+

+

+

+

+

+
+

+

+

+

+
+

+

+

+
+

+
+

+
+
+

+
+
+
+
+
+

+
+
+
+
+
+
+

+

+
+
+
+
+
+

+
+

+

+

+

+
+
+
+

+

+

+

+

+
+

+

+

+
+

+
+

+
+

+

+
+
+

+
+
+
+
+

+

+

+

+

+

+

+

+
+
+
+
+

+

+

+

+
+
+

+

+

+

+

+
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Table 7.

Continued.
Protein's Presence (+)
or Absence (-) in gels
MW

Spot#
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
A
B

C

(kDa)
69
65
64
62
85
81
85
73
71
70
69
69
68
70
69
65
64
50
49
50
53
55
56
50
44
39
40
38
38
38
41
38
43
31
92
42
82

Apparent

P!
5.8
5.5
5.8
5.8
9.3
9.3
9.0
9.2
9.2
8.5
7.8
8.5
7.5
7.3
6.9
7.3
6.2
9.0
8.8
8.5
7.8
7.3
7.0
6.8
9.4
9.4
9.0
8.4
8.6
6.4
6.1
6.2
5.8
7.3
6.9
7.8
9.3

ll
+
+
+
+
+
+
+·
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

-

ll

ll

li

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+

+
+
+

+
+
+
+
+
+
+

+
+
+
+
+
+
+

+
+
+
+
+
+

+

+
+
+
+

+
+
+
+

+

+

+

+

-

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

--

+

-

+
+
+

+

65

31, 32, 36, 41, 49, 56, 61, 62, 64 - 66, and 68 - 71 were
absent in Treatment Group IV.

Protein B was present in

Treatment Group IV, but absent in Treatment Group II.
Treatment Group V, supplemented with tamoxifen and
17-~-estradiol, produced a polypeptide map identifying 43
proteins (Figure 13).

Proteins 11 - 15, 17, 18, 21, 23,

24, 27, 31, 35, 36, 41, 49, 51, 53, 56, 61, 62, 64 - 66,
and 68 - 71 were absent in Treatment Group V.

Protein C

was present in Treatment Group V, but absent in Treatment
Group II.

Data for 2-D gel electrophoresis on all 4-cell

PIEs are presented in Table 7.
Protein profiles for a-cell PIEs are presented in
Figures 13 - 16.

The 2-D gel and polypeptide map for

Treatment Group II produced a total of 48 proteins
(Figure 13).
Treatment Group I, a-cell PIEs incubated in the
presence of 17-~-estradiol yielded a polypeptide map with
50 proteins (Figure 14).

Proteins 1, 20 and 42 were

absent in Treatment Group I.

Proteins A - D and E were

present in Treatment Group I, but absent in Treatment
Group II.
Tamoxifen supplemented a-cell PIEs in Treatment
Group IV, generated a polypeptide map composed of 44
proteins (Figure 15).

Proteins 1, 16 - 20, 29, 31,

33 - 35, 44, 46, and 47 were absent in Treatment Group
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Figure 13. Two-dimensional gel electrophoresis of a-cell
PIEs incubated in the ethanol control (Treatment Group
II). Thirty PIEs were loaded on to the gel. The upper
panel is a silver stained 2-D gel and the lower panel is
a polypeptide map in which numbers or letters have been
assigned to represent each silver stained spot. The
labeled polypeptides were tabulated in Table 8 for their
MW and apparent pI values.
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Figure 14. Two-dimensional gel electrophoresis of .B-cell
PIEs incubated in the presence of lµg of 17-~-estradiol
(Treatment Group I). Thirty PIEs were loaded on to the
gel. The upper panel is a silver stained 2-D gel and the
lower panel is a polypeptide map in which numbers or
letters have been assigned to represent each silver
stained spot. The labeled polypeptides were tabulated in
Table B for their MW and apparent pI values.
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Figure 15. Two-dimensional gel electrophoresis of 8 - cell
PIEs incubated in the presence of 3µg of tamoxifen
(Treatment Group IV). Thirty PIEs were loaded on to the
gel. The u pper panel is a silver stained 2-D gel and the
lower panel is a polypeptide map in which nu mbers or
letters have been ass i gned to represent each silver
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Figure 16. Two-dimensional gel electrophoresis of 8-cell
PIEs incubated in the presence of 3µg of tamoxifen and
l µg of 17-~-estradiol (Treatment Group V). Thirty PIEs
were loaded on to the gel. The upper panel is a silver
stained 2-D gel and the lower panel is a polypeptide map
in which numbers or letters have been assigned to
represent each silver stained spot. The labeled
polypeptides were tabulated in Table 8 for their MW and
apparent pI values.
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Table 8.

Characteristics of a-cell preimplantation
embryos separated by two-dimensional
polyacrylamide gel electrophoresis.
#1.:
ethanol-saline control,
#2: 1.7-13-estradiol,
#3: tamoxifen, #4: tamoxifen + 1.7-/3-estradiol.
Protein's Presence (+)
or Absence{-) in gels
MW

Spot_#
1
2
3
4
5
6
7
8
9
1.0
1.1.
1.2
13
1.4
1.5
1.6
1.7
1.8
1.9
20
21.
22
23
24
25
26
27
28
29
30
31.
32
33
34
35
36
37

Apparent

{kDal

~

ll

106
1.08
1.05
102
1.02
98
98
97
97
97
97
98
98
83
86
77
79
75
70
79
77
89
89
90
87
75
71.
66
63
62
61.
59
66
63
62
62
62

>9.6
>9.6
>9.6
9.3
9.0
9.0
8.6
8.4
8.2
7.9
7.7
7.6
7.1
8. l.
8.0
9.0
7.8
8 .1.
8.8
7.2
7.2
6.7
6.4
6.2
6.2
5.9
6.8
6.1
6.0
5.9
5.9
5.8
9.0
9.0
>9.6
8.2
7.9

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

ll

.u

li

+

+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+
+
+

+

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

-

+

+
+
+
+
+
+
+
+

-

+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+

+
+

·-

+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+

+

-

+
+
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Table 8.

Continued

MW

Spot#
38
39
40
41
42
43
44
45
46
47
48
A
B

C
D
E
F
G
H
I
J
K

L
M

N
0

p
Q
R

Nl
o1

(kDa)
61
61
58
43
44
48
46
33
32
31
<31
44
45
41
35
32
87
77
75
62
60
73
71
39
41
<31
88
87
89
59
50

Apparent

PI.
7.4
7.1
6.8
8.6
7.7
7.1
6.9
9.0
8.6
7.2
6.3
7.9
7.7
8,7
>9.6
7.9
>9.6
9.3
9.3
9.3
9.3
7.9
8.1
>9.6
<4.65
<4.65
7.6
7.5
7.4
<4.65
<4.65

Protein's Presence(+)
orAbsence (-) in gels

ll

ll

ll

li

+
+
+
+
+
+
+
+
+
+
+

+
+
+
+

+
+
+
+
+
+

+
+
+
+
+
+

+

+

+

+

--

--

----

-

+
+
+
+
+
+
+
+
+
+
+

--

+

-

+

+
+
+
+
+
+
+
+
+
+
+
+
+

--

+
+
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IV.

Proteins c, F - Q, and R were present in Treatment

Group IV, but absent in Treatment Group II.
Treatment Group V, supplemented with tamoxifen and
17-~-estradiol, produced a polypeptide map identifying 38
proteins (Figure 16).

Proteins 1, 15, 17 - 20, 35, 44,

46 and 47 were absent in Treatment Group V. Proteins D,
N1 , and o1 were present in Treatment Group V, but absent
in Treatment Group II.

Data for 2-D gel electrophoresis

on a-cell PIEs are presented in Tables.

CHAPTER IV

DISCUSSION

The application of molecular techniques, such as
electrophoresis, to analyze mammalian embryos has allowed
a better understanding of control mechanisms for early
embryogenesis.

Using data reported by numerous

researchers, Schultz (1986), concluded that proteins
synthesized from fertilization into the 2-cell embryo
were the result of utilizing maternally-derived mRNA's.
Schultz contended that the transition from maternal to
embryonic genomic control begins in the 2-cell stage.
This transition is probably both genetic and
environmentally influenced.

studies by Bowman & McLaren

(1970a and b) and Spielmann, et al.,

(1980), have shown

that PIEs cultured in vitro lag developmentally behind
embryos maintained in vivo.

This lag may be attributable

to the absence of developmental factors within the
maternal reproductive tract or to a reduction in some
endogenous factor.

steroids have been suggested to play

a role in influencing RNA production, protein synthesis,
and subsequent development.

The influence of an

estrogen, 17-~-estradiol, on PIE viability and protein
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profiles at the 2-cell, 4-cell and a-cell stages of
embryogenesis is reported in this research.

Viability Considerations

Viability studies for 2-cell, 4-cell and a-cell PIEs
demonstrated Whitten's Modified Medium to be efficient
for in vitro culturing of mouse embryos.

Control groups

for all embryonic stages successfully advanced to the
next embryonic stage during the 8 hour incubation period.
This was particularly significant for the 2-cell
treatment groups because of the reported 2-cell block
phenomenon for some mouse strains (Whitten and Biggers,
1968).

The addition of EDTA, as reported by Abramczuk,

et al. (1977), allowed successful advancement of 2-cell
PIEs, demonstrating the versatility of Whitten's Medium
supplemented with EDTA.
Culture experiments for 2-cell PIEs in the five
treatment groups were completed and the resultant data
are reported in Table 3.

Data reported in Table 3 show

that PIEs in the experimental control, Treatment Group
II, were not significantly inhibited in their development
by the presence of ethanol in the medium.

Because

·Treatment Groups II and III resulted in similar PIE
viabilities, ethanol influence was considered unimportant
as an experimental variable.
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Estrogen treated 2-cell PIEs were inhibited in their
advancement suggesting a toxic response to 17-~estradiol.

In Treatment Group I, PIE advancement was

significantly lower (p<0.05) than was the advancement
obtained for all other treatment groups.

These data

suggest that 17-~-estradiol was not required for 2-cell
PIE advancement, supporting-the genomic initiation theory
as proposed by Schultz (1986).

This theory states that

early embryogensis through the 2-cell stage was regulated
by macromolecules accumulated during oocyte maturation.
According to Schultz, expression of the embryonic genome
begins in late 2-cell PIEs.

Once the embryonic genome

has been activated, 17-~-estradiol stimulation should not
be toxic for later stages of embryogensis.
Tamoxifen treated 2-cell PIEs in Group IV progressed
to the 4-cell stage similar to Group II demonstrating a
lack of toxicity to embryo advancement.

Twenty-five PIEs

treated with tamoxifen and 17-~-estradiol in Group V
advanced to the 4-cell stage, a significantly higher
number than did PIEs treated with 17-~-estradiol in Group
I (11 of 60).

These data suggest that tamoxifen provided

a shielding effect to the toxicity of 17-~-estradiol at
the 2-cell stage.

While the tamoxifen treatment in Group

V provided some shielding from 17-~-estradiol the
advancement percentage to the 4-cell stage remained
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significantly less than that of the experimental control.
Data generated for the 2-cell viability study show 17-~estradiol to be inhibitory to 2-cell PIE advancement.
The results of the 4-cell and a-cell viability
studies are reported in Tables 4 and 5, respectively.
Comparison of data for 4-cell and a-cell cultured PIEs
show similar advancement percentages within treatment
groups.
PIEs in Treatment Groups II (ethanol-saline) and III
' '

(medium control) advanced to the next embryonic stage in
both the 4-cell and a-cell studies at percentage rates
similar to those reported in Table 3 for 2-cell PIEs.
These data for the control groups suggest consistency in
experimental design. and the application of laboratory
techniques.
Data reported in Tables 4 and 5 for 4-cell and
a-cell PIEs treated with 17-~-estradiol (Group I), show
that advancement percentages occurred at the same rate as
did those obtained for the experimental controls, unlike
the 17-~-estradiol treatment in 2-cell PIEs which were
significantly less than experimental controls.

The

addition of 17-~-estradiol to 4-cell and a-cell PIEs did
not enhance progression, but the toxic effects of
estrogen, as demonstrated in the 2-cell study, were not
observed.

These data for 4-cell and a-cell PIEs support
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the conclusion of Warner and Tollefson (1977), that
exogenously administered physiological concentrations of
17-$-estradiol would neither inhibit nor enhance embryo
advancement.
Tamoxifen treated (Group IV) 4-cell and a-cell PIEs
advanced to the next embryonic stage at a significantly
lower levels (p<0.05) than did the controls and 17-eestradiol treated groups.

Because tamoxifen treated

2-cell PIEs advanced to the 4-cell stage similar to the
experimental control, tamoxifen toxicity at the 4-cell
and a-cell PIE stages would not be expected.

Sengupta,

et al. (1977, 1982 and 1983), working with mouse morulas
and blastocysts, suggested that PIEs were capable of
endogenous estrogen production.

Dey and Dickmann (1974)

demonstrated the presence of steroidogenic enzymes in
late 2-cell PIEs.

Schultz (1986) stated that the

initiation of the embryonic genome occurred in late 2cell PIEs.

These reports suggest that the embryonic

genome, activated in late 2-cell PIEs, initiated the
production of endogenous estrogen.

Data for Treatment

Group IV, found in Tables 4 and 5, show tamoxifen to have
a negative effect on the advancement of 4-cell and a-cell
PIEs.

The negative influence of tamoxifen on 4-cell and

a-cell PIEs indicates the blockage of endogenously
produced estrogen.
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Data reported for Treatment Group V, tamoxifen plus
17-e-estradiol, for 4-cell and 8-cell PIEs (Tables 4 and
5) show significance (p<0.05) when compared to
experimental controls.

Results for the tamoxifen study

in Group IV, and the tamoxifen plus 17-e-estradiol in
Group V were similar.

These data further support

tamoxifen's ability to block endogenously produced
estrogen.

Additionally, data suggest the advancement of

4-cell and 8-cell PIEs to be estrogen dependent and that
the addition of lµg of 17-e-estradiol to be insufficient
to overcome the antiestogenic properties of tamoxifen.
Sengupta, et al. (1982), reported that administration of
17-e-estradiol reversed the inhibitory effects of
nafoxidine in mouse blastocysts.

The results obtained

for Group V suggest that tamoxifen may have greater
antiestrogenic properties than those of nafoxidine.

This

conclusion is based on 17-e-estradiol's inability to
reverse the inhibitory effects of tamoxifen in 4-cell and
8-cell cultured PIEs during the viability study.

Electrophoretic Considerations

Protein profiles for 2-cell PIEs were constructed
following 2-D polyacrylamide gel electrophoresis for each
treatment group.

The results of the mapped proteins-are

tabulated in Table 6.

Mapped proteins for the treatment
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groups for 2-cell PIEs were similar.

Proteins 1 - 46

occurred on all gels with two exceptions.

Protein 15 was

absent on the 17-~-estradiol map amd protein 44 was
absent on the tamoxifen plus 17-~-estradiol map.

The

absence of both proteins resulted from resolution
problems among the gels.

The absence of proteins 47 - 50

in t~e 17-~- estradiol treatment group suggest these
proteins were synthesized in the late 2-cell or early 4cell stage.

Because the 17-~-estradiol group did not

advance to the 4-cell stage, proteins 47 - 50 were not
synthesized.

Similarly, proteins 47 - 50 were absent in

the tamoxifen treated group, which'advanced to the 4-cell
·stage.

This suggests proteins 47 - 50 to be

dependent

on endogenous estrogen and these proteins were blocked by
tamoxifen.

In the tamoxifen plus 17-~-estradiol group,

proteins 47, 49 and 50 were absent as a result of
tamoxifen blockage.

The reappearance of protein 48

probably resulted from genomic reactivition influenced by
17-~-estradiol.
Protein 52, absent in tamoxifen treated PIEs,
apparently was estrogen dependent and synthezied at the
time of embryonic genome initiation.

Absence of proteins

57, A, B, c, D, and G resulted from resolution problems
and the interpretation of polypeptide maps within the
2-cell treatment groups.

The appearance of protein Eon
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the 17-~-estradiol map was art unexplained phenomenon.
Protein F appears to be tamoxifen dependent because it
occured only in the tamoxifen treated group.

Available

literature for tamoxifen suggests a lack of transcription
initiation, eliminating direct genomic influence on
protein synthesis (Jordan and Murphy, 1990).
protein Fis believed to be an artifact.

Therefore,

The occurrence

of protein H·in the tamoxifen plus 17-~-estradiol group
would be predictable if this protein was present in the
experimental control.

Examination of the experimental

control map indicates that protein 43 probably includes
protein H.

The perceived absence of protein Hin the

experimental control was a result of resolution.

Like

protein 48, protein H was estrogen dependent.
overall, the protein maps for the treatment groups
in the 2-cell study were similar.

Most of the proteins

were present on all maps or they were accounted for
through interpretation of the 2-D gels.

Because

embryonic genome activation does not occur until the late
2-cell stage, proteins present on the 2-cell maps were
either maternally derived proteins or they were proteins
synthesized from maternally derived mRNA.

Predictably,

the 2-cell polypeptide maps should be similar because of
this maternal derivation.

This conclusion was supported

by the 2-cell viability data (Table 3), which clearly
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shows that embryonic genome activation does not occur
until the late 2-cell stage.

Further, 2-cell PIE

advancement is not estrogen dependent.
Protein profiles constructed for the treatment
groups in the 4-cell PIE study demonstrate estrogen
dependency for progressive development.

Data from the

polypeptide maps reported in Table 7 show the
experimental control and 17-e-estradiol treated groups to
be similar, while the tamoxifen and tamoxifen plus 17-eestradiol groups were similar.

Of the 71 proteins

identified in the experimental control, 68 were found in
the 17-e-estradiol treated 4-cell PIEs.

Proteins 2 and 3

were absent in the 17-e-estradiol group as the result of
an unexplained resolution problem.

The absence of

protein 53 from the 17-e-estradiol group and the
tamoxifen plus 17-e-estradiol group suggests this protein
was estrogen sensitive.

Presence of protein A in the

17-e-estradiol group may be a result of estrogen
stimulation at the 8-cell stage.
In comparing the tamoxifen and tamoxifen plus 17-eestradiol groups to the experimental control, 27 proteins
present in the control were absent in both tamoxifen
treated groups.

Proteins absent in tamoxifen cultured

4-cell PIEs were 11 - 15, 17, 18, 21, 23, 24, 27, 31, 32,
35, 36, 41, 49, 56, 61, 62, 64 - 66, and 68 - 71.

These
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proteins were clearly estrogen dependent and their
production was inhibited by the presence of tamoxifen.
The reported absence of protein 51 in the 4-cell
tamoxifen plus 17-~-estradiol group can not be explained
at this time.

Results from other treatments, namely

Groups I and IV, show spot 51 as being distinct on
protein maps where supplements of tamoxifen or 17-~estradiol were adminstered.

Evidence suggests that

protein 51 should have been present on all gels.

An

explanation for the presence of proteins Band C in
tamoxifen treated groups may be due to the lack of embryo
progression in the 4-cell PIEs for both groups.

Data

suggest that proteins Band C were not carried into the
8-cell stage because of their absence in the experimental
control and 17-~-estradiol groups.
Viability data, reported in Table 4 show that the
experimental group (Group II) and the 17-~-estradiol
group (Group I) differ significantly from the tamoxifen
(Group IV) and tamoxifen plus 17-~-estradiol group (Group
V) with respect to 4-cell PIE advancement to the 8-cell
stage.

Data reported for protein profiles for 4-cell

treated PIEs presented in Table 7 support the viability
data.

It can be concluded from these data that 4-cell

progression was estrogen dependent and that tamoxifen
exhibited antiestrogenic properties.
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The results of the a-cell 2-D gel study (Table 8)
were similar to the 4-cell study when comparing the
experimental control and 17-B-estradiol treatments.

Of

the 48 proteins present in the control, 45 were
identified for the 17-B-estradiol group.

The absence of

protein 1 was most likely the result of a lack of
resolution on the 2-D gels.

Protein 20 appears in the 8-

cell experimental control as one of several proteins
present in the 4-cell treated PIEs.

The absence of this

protein in 17-B-estradiol treated a-cell PIES may reflect
the inactivation of protein 20.

In the 17-B-estradiol

treatment, protein 42 was reported as being absent.
However, on the 17-B-estradiol map, the new proteins A
and B were positioned at approximately the same location
as was protein 42.

This suggests that proteins A and B

were identified as an interpretative error in reading
protein 42 on the 2-D gel for Group I.

Proteins C and D

reported as present in the 17-B-estradiol treatment may
be the result of resolution problems in mapping proteins
41 and 45, respectively.

The absence of protein Eon the

experimental control was most likely the result a
deformity within the 2-D gel.
Tamoxifen treated a-cell PIEs lacked 13 of the 48
proteins present in the experimental control.

The

absence of these proteins suggest an estrogen dependence
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and these results were similar to those reported for 4cell treated PIEs.

Estrogen dependent proteins absent in

tamoxifen treated PIEs were 16 - 20, 29, 31, 33 - 35, 44,
46, 47, and E.

Proteins F ~Mand P - R, reported for

tamoxifen treated 8-cell PIEs, were probably remnants
from the 8-cell stage that were maintained in this
treatment group due to the lack of advancement among
tamoxifen treated 8-cell PIEs.

Among tamoxifen plus

17-e-estradiol, treated PIEs, the absence of proteins
17 - 20, 35, 44, 46, 47 and E reflect estrogen dependent
proteins blocked by·tamoxifen.

The presence of proteins

16, 29, 31, 33, and 34 in the tamoxifen plus 17-eestradiol treatment suggests a reversal in the effects of
tamoxifen in the presence of 17-e-estradiol.

This is

consistent with the findings of Sengupta, et al. (1982),
for the reversal of nafoxidine by 17-e-estradiol mouse
blastocyst.
The protein maps for tamoxifen and tamoxifen plus
17-e-estradiol for 8-cell PIEs generated 2 proteins on
each gel that cannot be explained at this time.

Proteins

N and O on the tamoxifen map and N1 and o 1 on the
tamoxifen plus 17-e-estradiol map were unique to those
gels.

Because these spots were located at the extreme

positive end of the tube gel, their identification as PIE
proteins was suspect.
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Overall, protein profiles for the a-cell treated
PIEs were similar to those generated for 4-cell treated
PIEs.

The experimental group and the 17-~-estradiol

group were similar in their protein profiles.

Tamoxifen

treated 8-cell PIEs, were inhibited in their development
-by a demonstrated blockage of estrogen dependent
proteins .•

The presence of additional proteins on the

tamoxifen map were proteins present at the time of
incubation. The protein map for the tamoxifen plus 17-~estradiol treatment supports the results obtained from
the tamoxifen group.

Most of the proteins inhibited by

tamoxifen in Treatment Group IV were similarly inhibited
in Treatment Group V.

Data from

Group V suggest that

the presence of 17-~-estradiol had a reversal influence
on selected tamoxifen inhibited proteins.

Further, the

data from Treatment Groups IV and V suggest estrogen
dependency for protein production when compared to Groups
I and II.

These conclusions are consistent with the

results of the viability data for a-cell PIE advancement
and suggest the presence of endogenous estrogen
production by 8-cell PIEs.

Summary

Resultant data from the viability and electrophoretic studies were consistent within treatment groups
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for 2-cell, 4-cell and 8-cell PIEs.

Culture experiments

produced viable 2-cell PIEs at a significantly higher
rate in the experimental control and tamoxifen
supplemented group than did treatment groups receiving
17-~-estradiol.

Among 4-cell and 8-cell cultured PIEs,

the ~xperimental control and the 17-~-estradiol treatment
groups yielded significantly higher percentages of viable
PIEs than did tamoxifen supplemented groups.

These data

support the concept of embryonic genome initation at the
)

late 2-cell PIE stage as proposed by Schultz (1986).
The apparent toxicity of 17-~-estradiol on 2-cell
PIEs clearly demonstrates that the second cleavage
division lacks estrogen dependence.

Proteins identified

on 2-cell, 2-D gels for all treatment groups were
generally consistent.

These protein profiles illustrate

the dependence of early embryogenesis on maternallyderived macromolecules (Chen, et al., 1980;
1981a and 1985;

Van Blerkom,

Van Blerkom and Runner, 1989;

Magnuson

and Epstein, 1987).
Viability studies for 4-cell and 8-cell PIEs
produced similar results for specific PIE treatments.
Tamoxifen treated groups yielded significantly fewer
advancing PIEs as compared to the 17-~-estradiol
treatment.

These results support the non-steroidal

antiestrogenic properties reported for other
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antiestrogens such as nafoxidine and CI-628 (Clark, et
al., 1973 and 1974;

Ferguson and Katzenellenbogen, 1977;

Katzenellenbogen, et al., 1979).

Further, the

significant reduction in PIE advancement within the
tamoxifen treated group, as compared to the experimental
control, demonstrates the suggested production of
endogenous estrogen by PIEs (Dey and Dickmann, 1974;
Dickmann, et al., 1976).
Protein profiles produced for tamoxifen treated
4-cell and a-cell PIEs show a reduction in protein
content as compared to 17-~-estradiol treated PIEs.
Because tamoxifen treated PIEs failed to advance to the
morula stage, this reduction in protein synthesis
suggests that 4-cell and 8-cell PIE advancement is
estrogen dependent.

Therefore, the similarity between

the experimental control and the 17-~-estradiol treatment
group, in both viability and 2-D gel studies, would
suggest the occurrence of endogenous estrogen.

Warner

and Tollefson (1977), reported that exogenous supplements
of physiological concentrations of 17-~-estradiol would
not enhance PIE viability.

Data produced in both

viability and electrophoretic studies confirm this
conclusion, however, electrophoretic data show that
exogenous estrogen does not stimulate protein production.
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Comparision of the tamoxifen plus 17-~-estradiol
4-cell and a-cell treatments to those of the 17-~estradiol treatment show significant reduction in PIE
advancement.

Within the 4-cell treatments, viability and

electrophoretic data suggest that estrogen blockage is
complete.

In viability studies with a-cell PIEs Roy, et

al. (1981), Reported that lµg of 17-~-estradiol would not
reverse the effects of 3µg of nafoxidine.

Data produced

for'tamoxifen plus 17-~-estradiol treated PIEs show
similar results for PIE viability, but, electrophoretic
data suggest that some protein reversal had occurred.
These protein reversals were not significant enough to
reverse PIE viability at the a-cell stage.

Sengupta, et

al. (1977, 1982 and 1983), reported viability reversal
for nafoxidine treated mouse morulas and blastocysts when
exogenous 17-~-estradiol was added to nafoxidine
supplemented culture medium.

While the tamoxifen plus

17-~-estradiol viability and electrophoretic data for 8cell PIEs does not support the conclusions of Sengupta,
et al., the difference is probably due to the stage of
embryogeneis.
Overall, data generated:

(1)

support the concept

of embryonic genome initation at the late 2-cell stage,
(2)

show that enhancement of protein synthesis will not

result from exogenous supplements of 17-~-estradiol in
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2-cell, 4-cell, and 8-cell PIEs,

and

(3)

demonstrate

that_tamoxifen exerts antiestrogenic properties resulting
in decreased protein synthesis and PIE viability.

In

addition, data suggest that 4-cell and 8-cell PIEs are
estrogen dependent and that endogenous estrogen
production influences 4-cell and a-cell PIE
embryogenesis.

CHAPTER V

CONCLUSIONS

Data generated through viability and 2-D gel
electrophoresis studies clearly show that exogenously
administered 17-0-estradiol supplements to Whitten's
Modified Medium does not enhance protein synthesis in
2-cell, 4-cell, and a-cell preimplantation embryos.
Administration of 11-0-estradiol was toxic to 2-cell PIEs
but among 4-cell and a-cell cultured PIEs, 11-0-estradiol
data were equal to that of control treatments.

In 4-cell

and a-cell PIE electrophoretic studies, protein profiles
were neither enhanced nor inhibited by 17-0-estradiol.
Therefore, the null hypothesis is accepted;

that 17-0-

estradiol was without effect on PIE protein profiles.
Tamoxifen treated 2-cell PIEs produced results
similar to those of the experimental control, suggesting
a lack of estrogen influence on 2-cell PIE advancement.
Within 4-cell and a-cell treatments, data show estrogen
dependence for PIE advancement.

Tamoxifen treated PIE

cultures in both viability and electrophoretic studies
were blocked or inhibited in their development.
data demonstate the antiestrogenic properties of
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These
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tamoxifen on 4-cell and a-cell PIEs.

Therefore, the

hypothesis that tamoxifen inhibits 17-~-estradiol in
mouse PIEs is accepted.
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